Vanguard Group’s CVS Health CVS Stock Holding History

Vanguard Group’s Portfolio CVS Stock Details CVS Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$8.31B	Buy	120,399,131 +2,063,737	+2%	+$142M	0.13%	133
2025 Q1	$8.02B	Buy	118,335,394 +969,027	+0.8%	+$65.7M	0.14%	119
2024 Q4	$5.27B	Sell	117,366,367 -250,065	-0.2%	-$11.2M	0.09%	190
2024 Q3	$7.4B	Buy	117,616,432 +1,266,310	+1%	+$79.6M	0.13%	131
2024 Q2	$6.87B	Buy	116,350,122 +232,632	+0.2%	+$13.7M	0.13%	130
2024 Q1	$9.26B	Sell	116,117,490 -1,578,795	-1%	-$126M	0.18%	96
2023 Q4	$9.29B	Buy	117,696,285 +533,659	+0.5%	+$42.1M	0.2%	83
2023 Q3	$8.18B	Buy	117,162,626 +485,744	+0.4%	+$33.9M	0.2%	88
2023 Q2	$8.07B	Buy	116,676,882 +341,411	+0.3%	+$23.6M	0.19%	89
2023 Q1	$8.64B	Sell	116,335,471 -1,197,901	-1%	-$89M	0.22%	81
2022 Q4	$11B	Buy	117,533,372 +1,598,531	+1%	+$149M	0.3%	61
2022 Q3	$11.1B	Buy	115,934,841 +1,726,512	+2%	+$165M	0.33%	47
2022 Q2	$10.6B	Buy	114,208,329 +2,342,667	+2%	+$217M	0.3%	58
2022 Q1	$11.3B	Buy	111,865,662 +2,628,740	+2%	+$266M	0.27%	63
2021 Q4	$11.3B	Buy	109,236,922 +879,616	+0.8%	+$90.7M	0.26%	66
2021 Q3	$9.2B	Buy	108,357,306 +861,567	+0.8%	+$73.1M	0.23%	77
2021 Q2	$8.97B	Buy	107,495,739 +1,170,549	+1%	+$97.7M	0.22%	77
2021 Q1	$8B	Buy	106,325,190 +941,267	+0.9%	+$70.8M	0.22%	77
2020 Q4	$7.2B	Sell	105,383,923 -773,094	-0.7%	-$52.8M	0.21%	79
2020 Q3	$6.2B	Sell	106,157,017 -1,050,300	-1%	-$61.3M	0.21%	83
2020 Q2	$6.97B	Sell	107,207,317 -531,433	-0.5%	-$34.5M	0.25%	71
2020 Q1	$6.39B	Buy	107,738,750 +2,930,548	+3%	+$174M	0.27%	67
2019 Q4	$7.79B	Buy	104,808,202 +1,399,688	+1%	+$104M	0.27%	66
2019 Q3	$6.52B	Buy	103,408,514 +1,040,615	+1%	+$65.6M	0.24%	69
2019 Q2	$5.58B	Buy	102,367,899 +1,167,143	+1%	+$63.6M	0.21%	80
2019 Q1	$5.46B	Sell	101,200,756 -8,012,696	-7%	-$432M	0.21%	82
2018 Q4	$7.16B	Buy	109,213,452 +24,339,638	+29%	+$1.59B	0.32%	56
2018 Q3	$6.68B	Buy	84,873,814 +1,445,887	+2%	+$114M	0.26%	70
2018 Q2	$5.37B	Buy	83,427,927 +4,892,512	+6%	+$315M	0.22%	76
2018 Q1	$4.89B	Sell	78,535,415 -43,392	-0.1%	-$2.7M	0.21%	81
2017 Q4	$5.7B	Buy	78,578,807 +1,046,397	+1%	+$75.9M	0.25%	69
2017 Q3	$6.3B	Buy	77,532,410 +974,813	+1%	+$79.3M	0.29%	56
2017 Q2	$6.16B	Buy	76,557,597 +1,056,265	+1%	+$85M	0.3%	53
2017 Q1	$5.93B	Buy	75,501,332 +1,120,254	+2%	+$87.9M	0.3%	51
2016 Q4	$5.87B	Buy	74,381,078 +1,352,472	+2%	+$107M	0.33%	47
2016 Q3	$6.5B	Buy	73,028,606 +1,483,616	+2%	+$132M	0.38%	44
2016 Q2	$6.85B	Buy	71,544,990 +15,979	+0%	+$1.53M	0.43%	42
2016 Q1	$7.42B	Buy	71,529,011 +2,578,178	+4%	+$267M	0.48%	35
2015 Q4	$6.74B	Buy	68,950,833 +1,086,137	+2%	+$106M	0.45%	39
2015 Q3	$6.55B	Sell	67,864,696 -45,257	-0.1%	-$4.37M	0.47%	33
2015 Q2	$7.12B	Buy	67,909,953 +671,875	+1%	+$70.5M	0.48%	32
2015 Q1	$6.94B	Sell	67,238,078 -817,733	-1%	-$84.4M	0.47%	34
2014 Q4	$6.55B	Buy	68,055,811 +1,185,384	+2%	+$114M	0.47%	35
2014 Q3	$5.32B	Buy	66,870,427 +658,343	+1%	+$52.4M	0.41%	38
2014 Q2	$4.99B	Buy	66,212,084 +786,789	+1%	+$59.3M	0.39%	40
2014 Q1	$4.9B	Buy	65,425,295 +8,938,722	+16%	+$669M	0.41%	39
2013 Q4	$4.04B	Sell	56,486,573 -743,769	-1%	-$53.2M	0.36%	47
2013 Q3	$3.25B	Buy	57,230,342 +1,471,543	+3%	+$83.5M	0.32%	51
2013 Q2	$3.19B	Buy	+55,758,799	New	+$3.19B	0.33%	48